SEOUL PHARMA CO.,LTD Logo

SEOUL PHARMA CO.,LTD

A pharmaceutical firm specializing in Orally Disintegrating Film (ODF) technology.

018680 | KO

Overview

Corporate Details

ISIN(s):
KR7018680009
LEI:
Country:
South Korea
Address:
충청북도 청주시 흥덕구 오송읍 오송생명6로 124-31 서울제약 오송공장, 청주시

Description

Seoul Pharma Co., Ltd. is a pharmaceutical company engaged in the research, development, manufacturing, and sale of pharmaceutical products. The company specializes in innovative drug delivery systems, with a core competency in Orally Disintegrating Film (ODF) technology. Its product portfolio includes a wide range of prescription and over-the-counter medications. Key therapeutic areas cover cardiovascular and respiratory systems, as well as anti-infective agents such as antibacterials, antifungals, and antivirals. The company also produces vitamins and antibiotics, aiming to improve health outcomes through its cutting-edge technological capabilities.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-08-14 00:00
반기보고서 (2025.06)
Korean 953.1 KB
2025-05-15 00:00
분기보고서 (2025.03)
Korean 915.1 KB
2025-04-18 00:00
[기재정정]주주총회소집공고
Korean 92.8 KB
2025-03-28 00:00
정기주주총회결과
Korean 22.4 KB
2025-03-20 00:00
감사보고서제출
Korean 18.5 KB
2025-03-20 00:00
사업보고서 (2024.12)
Korean 480.3 KB
2025-03-17 00:00
[기재정정]주주총회소집결의
Korean 14.3 KB
2025-03-13 00:00
주주총회소집결의
Korean 11.2 KB
2025-03-13 00:00
주주총회소집공고
Korean 89.8 KB
2025-03-13 00:00
주주총회집중일개최사유신고
Korean 5.5 KB
2025-02-07 00:00
매출액또는손익구조30%(대규모법인은15%)이상변동
Korean 11.1 KB
2024-12-13 00:00
주주명부폐쇄기간또는기준일설정
Korean 4.5 KB
2024-11-14 00:00
분기보고서 (2024.09)
Korean 818.8 KB
2024-08-14 00:00
반기보고서 (2024.06)
Korean 836.4 KB
2024-05-14 00:00
분기보고서 (2024.03)
Korean 734.1 KB

Automate Your Workflow. Get a real-time feed of all SEOUL PHARMA CO.,LTD filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for SEOUL PHARMA CO.,LTD

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for SEOUL PHARMA CO.,LTD via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

4BASEBIO PLC Logo
Manufactures GMP-grade synthetic DNA for next-generation therapeutics and vaccines.
United Kingdom
4BB
4D Molecular Therapeutics, Inc. Logo
Develops genetic medicines using AAV vectors for ophthalmology and pulmonology diseases.
United States of America
FDMT
4SC AG Logo
Biopharmaceutical company with no products under development or operational business.
Germany
VSC
60 DEGREES PHARMACEUTICALS, INC. Logo
Develops and commercializes medicines for infectious diseases, focusing on tropical illnesses.
United States of America
SXTP
89bio, Inc. Logo
Clinical-stage biopharma developing therapies for liver and cardiometabolic diseases.
United States of America
ETNB
Aardvark Therapeutics, Inc. Logo
Clinical-stage biopharma developing therapeutics for hunger and metabolic diseases.
United States of America
AARD
ABBOTT LABORATORIES Logo
Global healthcare company in medical devices, diagnostics, nutrition & pharmaceuticals.
United States of America
ABT
AbbVie Inc. Logo
A research-based biopharmaceutical company developing and manufacturing medicines.
United States of America
ABBV
AbCellera Biologics Inc. Logo
Discovers and develops antibody-based therapeutics using a proprietary platform.
United States of America
ABCL
Develops antibody-based therapeutics using CAR-T, NEST, and AffiMab platforms.
South Korea
174900

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.